EXELA TECHNOLOGIES INC (XELA) Stock Fundamental Analysis

NASDAQ:XELA • US30162V8054

1.15 USD
-0.83 (-41.92%)
At close: Nov 7, 2024
1.2 USD
+0.05 (+4.35%)
After Hours: 11/7/2024, 8:12:48 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Overall XELA gets a fundamental rating of 1 out of 10. We evaluated XELA against 87 industry peers in the IT Services industry. Both the profitability and financial health of XELA have multiple concerns. XELA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • XELA had negative earnings in the past year.
  • In the past year XELA had a positive cash flow from operations.
  • XELA had negative earnings in each of the past 5 years.
  • XELA had negative operating cash flow in 4 of the past 5 years.
XELA Yearly Net Income VS EBIT VS OCF VS FCFXELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M -300M -400M -500M

1.2 Ratios

  • The Return On Assets of XELA (-18.44%) is worse than 79.76% of its industry peers.
  • XELA has a Return On Invested Capital (0.64%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -18.44%
ROE N/A
ROIC 0.64%
ROA(3y)-31.16%
ROA(5y)-29.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XELA Yearly ROA, ROE, ROICXELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K 2K

1.3 Margins

  • With a Operating Margin value of 0.14%, XELA perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
  • XELA has a Gross Margin of 22.23%. This is in the lower half of the industry: XELA underperforms 73.81% of its industry peers.
  • XELA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.14%
PM (TTM) N/A
GM 22.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y-1.6%
XELA Yearly Profit, Operating, Gross MarginsXELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so XELA is destroying value.
  • Compared to 1 year ago, XELA has more shares outstanding
  • The debt/assets ratio for XELA is higher compared to a year ago.
XELA Yearly Shares OutstandingXELA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
XELA Yearly Total Debt VS Total AssetsXELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of -3.85, we must say that XELA is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -3.85, XELA is not doing good in the industry: 89.29% of the companies in the same industry are doing better.
  • XELA has a debt to FCF ratio of 45.59. This is a negative value and a sign of low solvency as XELA would need 45.59 years to pay back of all of its debts.
  • The Debt to FCF ratio of XELA (45.59) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 45.59
Altman-Z -3.85
ROIC/WACC0.08
WACC8.14%
XELA Yearly LT Debt VS Equity VS FCFXELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.38 indicates that XELA may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.38, XELA is doing worse than 95.24% of the companies in the same industry.
  • A Quick Ratio of 0.35 indicates that XELA may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.35, XELA is not doing good in the industry: 95.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.35
XELA Yearly Current Assets VS Current LiabilitesXELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • XELA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.10%, which is quite impressive.
  • The Revenue has decreased by -5.15% in the past year.
  • The Revenue has been decreasing by -7.67% on average over the past years.
EPS 1Y (TTM)97.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.63%
Revenue 1Y (TTM)-5.15%
Revenue growth 3Y-6.28%
Revenue growth 5Y-7.67%
Sales Q2Q%-9.98%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-18.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.52%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XELA Yearly Revenue VS EstimatesXELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
XELA Yearly EPS VS EstimatesXELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • XELA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year XELA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XELA Price Earnings VS Forward Price EarningsXELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • 60.71% of the companies in the same industry are more expensive than XELA, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of XELA indicates a rather cheap valuation: XELA is cheaper than 98.81% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.31
EV/EBITDA 17.97
XELA Per share dataXELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • XELA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

EXELA TECHNOLOGIES INC

NASDAQ:XELA (11/7/2024, 8:12:48 PM)

After market: 1.2 +0.05 (+4.35%)

1.15

-0.83 (-41.92%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-06
Earnings (Next)11-28
Inst Owners8.43%
Inst Owner Change0%
Ins Owners1296.91%
Ins Owner Change0%
Market Cap7.33M
Revenue(TTM)1.02B
Net Income(TTM)-108.41M
Analysts43.33
Price Target2.04 (77.39%)
Short Float %N/A
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend3.37
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.31
P/OCF 0.2
P/B N/A
P/tB N/A
EV/EBITDA 17.97
EPS(TTM)-17.03
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)3.73
FCFY324.44%
OCF(TTM)5.7
OCFY495.67%
SpS160.44
BVpS-141.88
TBVpS-191.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.44%
ROE N/A
ROCE 0.82%
ROIC 0.64%
ROICexc 0.78%
ROICexgc N/A
OM 0.14%
PM (TTM) N/A
GM 22.23%
FCFM 2.33%
ROA(3y)-31.16%
ROA(5y)-29.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y-1.6%
F-Score6
Asset Turnover1.74
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 45.59
Debt/EBITDA 17.34
Cap/Depr 21.79%
Cap/Sales 1.23%
Interest Coverage 0.02
Cash Conversion 61.52%
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.35
Altman-Z -3.85
F-Score6
WACC8.14%
ROIC/WACC0.08
Cap/Depr(3y)23.88%
Cap/Depr(5y)21.7%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.63%
EPS Next Y-18.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.15%
Revenue growth 3Y-6.28%
Revenue growth 5Y-7.67%
Sales Q2Q%-9.98%
Revenue Next Year5.52%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year295.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y137.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y192.16%
OCF growth 3YN/A
OCF growth 5Y-31.51%

EXELA TECHNOLOGIES INC / XELA FAQ

Can you provide the ChartMill fundamental rating for EXELA TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 1 / 10 to XELA.


What is the valuation status for XELA stock?

ChartMill assigns a valuation rating of 2 / 10 to EXELA TECHNOLOGIES INC (XELA). This can be considered as Overvalued.


Can you provide the profitability details for EXELA TECHNOLOGIES INC?

EXELA TECHNOLOGIES INC (XELA) has a profitability rating of 1 / 10.


Can you provide the financial health for XELA stock?

The financial health rating of EXELA TECHNOLOGIES INC (XELA) is 0 / 10.


Can you provide the expected EPS growth for XELA stock?

The Earnings per Share (EPS) of EXELA TECHNOLOGIES INC (XELA) is expected to decline by -18.13% in the next year.